Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2-STEP trial of 2-iminobiotin in neonates with perinatal asphyxia undergoing therapeutic hypothermia
2014-004265-25Phase 2Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of 2-iminobiotin in asphyxia neonatorum and hypoxic-ischemic encephalopathy (HIE), sponsored by University Medical Center Utrecht. Primary endpoints: Safety and tolerability and Pharmacokinetic profile of 2-iminobiotin. Started Jan 2015; status: completed.
02
Drugs
2-iminobiotin
03
Conditions
asphyxia neonatorumhypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on 2014-004265-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004265-25.